The UK has reached an agreement to deliver the first 5 million doses of a new vaccine developed by the US biotechnology company Modern. The vaccine could be given from the spring of 2021 if approved by the regulator. England’s health secretary Matt Hancock has warned that safety data is limited and the company’s production facilities are not yet fully developed. Modern says trials so far show that the vaccine is nearly 95% effective. It has been tested by many people. It can be stored at normal refrigerated temperatures, making it much easier to distribute than recently announced Pfizer vaccines. Huw Edwards presents a report by BBC editor Fergus Walsh on BBC News Ten. Please subscribe HERE http://bit.ly/1rbfUog .
to request, modification Contact us at Here or [email protected]